Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Serum complement activation is implicated in the pathogenesis of CHF

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

Data and safety monitoring board recommends continuation of Bextra study

Nov. 13, 1998

First clinical results reported for novel gene therapy in coronary artery disease

Nov. 12, 1998

NOS-inhibitory condensed piperidines disclosed by Ono

Nov. 12, 1998

ETA antagonist has positive effects on pulmonary vascular resistance in patients with HF

Nov. 12, 1998

Levosimendan clinical results presented this week at AHA meeting

Nov. 12, 1998

Photoangioplasty with Antrin reduces atherosclerotic plaque in rabbit models

Nov. 11, 1998

Selective inhibitors of vascular wall, microsomal ACAT developed at Kowa

Nov. 11, 1998

Unexpected adverse events encountered with bosentan in REACH-1 trial

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...